|
1
|
Ozawa Y, Suda T, Naito T, Enomoto N,
Hashimoto D, Fujisawa T, Nakamura Y, Inui N, Nakamura H and Chida
K: Cumulative incidence of and predictive factors for lung cancer
in IPF. Respirology. 14:723–728. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Artinian V and Kvale PA: Cancer and
interstitial lung disease. Curr Opin Pulm Med. 10:425–434. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Carninci P, Kasukawa T, Katayama S, Gough
J, Frith MC, Maeda N, Oyama R, Ravasi T, Lenhard B, Wells C, et al:
The transcriptional landscape of the mammalian genome. Science.
309:1559–1563. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mehler MF and Mattick JS: Noncoding RNAs
and RNA editing in brain development, functional diversification,
and neurological disease. Physiol Rev. 87:799–823. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kaelin WG Jr: The emerging p53 gene
family. J Natl Cancer Inst. 91:594–598. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
American Thoracic Society. Idiopathic
pulmonary fibrosis, . Diagnosis and treatment. International
consensus statement. American Thoracic Society (ATS) and the
European Respiratory Society (ERS). Am J Respir Crit Care Med.
161:646–664. 2000.PubMed/NCBI
|
|
7
|
Silver N, Best S, Jiang J and Thein SL:
Selection of housekeeping genes for gene expression studies in
human reticulocytes using real-time PCR. BMC Mol Biol. 7:332006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Busch SE, Moser RD, Gurley KE,
Kelly-Spratt KS, Liggitt HD and Kemp CJ: ARF inhibits the growth
and malignant progression of non-small-cell lung carcinoma.
Oncogene. 33:2665–2673. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Collard HR and Pantilat SZ: Dyspnea in
interstitial lung disease. Curr Opin Support Palliat Care.
2:100–104. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
King TE Jr, Pardo A and Selman M:
Idiopathic pulmonary fibrosis. Lancet. 378:1949–1961. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Spain DM: The association of terminal
bronchiolar carcinoma with chronic interstitial inflammation and
fibrosis of the lungs. Am Rev Tuberc. 76:559–566. 1957.PubMed/NCBI
|
|
12
|
Song DH, Choi IH, Ha SY, Han KM, Lee JJ,
Hong ME, Jeon K, Chung MP, Kim J and Han J: Usual interstitial
pneumonia with lung cancer: Clinicopathological analysis of 43
cases. Korean J Pathol. 48:10–16. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Le Jeune I, Gribbin J, West J, Smith C,
Cullinan P and Hubbard R: The incidence of cancer in patients with
idiopathic pulmonary fibrosis and sarcoidosis in the UK. Respir
Med. 101:2534–2540. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Matsushita H, Tanaka S, Saiki Y, Hara M,
Nakata K, Tanimura S and Banba J: Lung cancer associated with usual
interstitial pneumonia. Pathol Int. 45:925–932. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Turner-Warwick M, Lebowitz M, Burrows B
and Johnson A: Cryptogenic fibrosing alveolitis and lung cancer.
Thorax. 35:496–499. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Stack BH, Grant IW, Irvine WJ and Moffat
MA: Idiopathic diffuse interstitial lung disease. A review of 42
cases. Am Rev Respir Dis. 92:939–948. 1965.PubMed/NCBI
|
|
17
|
Tomassetti S, Gurioli C, Ryu JH, Decker
PA, Ravaglia C, Tantalocco P, Buccioli M, Piciucchi S, Sverzellati
N, Dubini A, et al: The impact of lung cancer on survival of
idiopathic pulmonary fibrosis. Chest. 147:157–164. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Aubry MC, Myers JL, Douglas WW, Tazelaar
HD, Washington Stephens TL, Hartman TE, Deschamps C and Pankratz
VS: Primary pulmonary carcinoma in patients with idiopathic
pulmonary fibrosis. Mayo Clin Proc. 77:pp. 763–770. 2002;
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nagai A, Chiyotani A, Nakadate T and Konno
K: Lung cancer in patients with idiopathic pulmonary fibrosis.
Tohoku J Exp Med. 167:231–237. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Park J, Kim DS, Shim TS, Lim CM, Koh Y,
Lee SD, Kim WS, Kim WD, Lee JS and Song KS: Lung cancer in patients
with idiopathic pulmonary fibrosis. Eur Respir J. 17:1216–1219.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kishi K, Homma S, Kurosaki A, Motoi N and
Yoshimura K: High-resolution computed tomography findings of lung
cancer associated with idiopathic pulmonary fibrosis. J Comput
Assist Tomogr. 30:95–99. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kim Y, Kwon Y, Oh I, Kim K, Kim S, Ryu J,
Yum H, Yong S, Lee K, Lee C, et al: National survey of lung cancer
in Korea, 2005. J Lung Cancer. 6:67–73. 2007. View Article : Google Scholar
|
|
23
|
Lee C, Kang KH, Koh Y, Chang J, Chung HS,
Park SK, Yoo K and Song JS: Characteristics of lung cancer in
Korea, 1997. Lung Cancer. 30:15–22. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hironaka M and Fukayama M: Pulmonary
fibrosis and lung carcinoma: A comparative study of metaplastic
epithelia in honeycombed areas of usual interstitial pneumonia with
or without lung carcinoma. Pathol Int. 49:1060–1066. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Takahashi T, Munakata M, Ohtsuka Y,
Nisihara H, Nasuhara Y, Kamachi-Satoh A, Dosaka-Akita H, Homma Y
and Kawakami Y: Expression and alteration of ras and p53 proteins
in patients with lung carcinoma accompanied by idiopathic pulmonary
fibrosis. Cancer. 95:624–633. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kawasaki H, Ogura T, Yokose T, Nagai K,
Nishiwaki Y and Esumi H: p53 gene alteration in atypical epithelial
lesions and carcinoma in patients with idiopathic pulmonary
fibrosis. Hum Pathol. 32:1043–1049. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Oshikawa K and Sugiyama Y: Serum anti-p53
autoantibodies from patients with idiopathic pulmonary fibrosis
associated with lung cancer. Respir Med. 94:1085–1091. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhong G, Chen X, Fang X, Wang D, Xie M and
Chen Q: Fra-1 is upregulated in lung cancer tissues and inhibits
the apoptosis of lung cancer cells by the P53 signaling pathway.
Oncol Rep. 35:447–453. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu ZH, Wang MH, Ren HJ, Qu W, Sun LM,
Zhang QF, Qiu XS and Wang EH: Interleukin 7 signaling prevents
apoptosis by regulating bcl-2 and bax via the p53 pathway in human
non-small cell lung cancer cells. Int J Clin Exp Pathol. 7:870–881.
2014.PubMed/NCBI
|
|
30
|
Li S, Li X, Zhao H, Gao M, Wang F and Li
W: Overexpression of microRNA-125a-3p effectively inhibits the cell
growth and invasion of lung cancer cells by regulating the mouse
double minute 2 homolog/p53 signaling pathway. Mol Med Rep.
12:5482–5486. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chuang CY, Liu HC, Wu LC, Chen CY, Chang
JT and Hsu SL: Gallic acid induces apoptosis of lung fibroblasts
via a reactive oxygen species-dependent ataxia telangiectasia
mutated-p53 activation pathway. J Agric Food Chem. 58:2943–2951.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fu X, Ravindranath L, Tran N, Petrovics G
and Srivastava S: Regulation of apoptosis by a prostate-specific
and prostate cancer-associated noncoding gene, PCGEM1. DNA Cell
Biol. 25:135–141. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gupta RA, Shah N, Wang KC, Kim J, Horlings
HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al: Long
non-coding RNA HOTAIR reprograms chromatin state to promote cancer
metastasis. Nature. 464:1071–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cao G, Zhang J, Wang M, Song X, Liu W, Mao
C and Lv C: Differential expression of long non-coding RNAs in
bleomycin-induced lung fibrosis. Int J Mol Med. 32:355–364. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ricciuti B, Mencaroni C, Paglialunga L,
Paciullo F, Crinò L, Chiari R and Metro G: Long noncoding RNAs: New
insights into non-small cell lung cancer biology, diagnosis and
therapy. Med Oncol. 33:182016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang HM, Lu JH, Chen WY and Gu AQ:
Upregulated lncRNA-UCA1 contributes to progression of lung cancer
and is closely related to clinical diagnosis as a predictive
biomarker in plasma. Int J Clin Exp Med. 8:11824–11830.
2015.PubMed/NCBI
|
|
37
|
Khandelwal A, Bacolla A, Vasquez KM and
Jain A: Long non-coding RNA: A new paradigm for lung cancer. Mol
Carcinog. 54:1235–1251. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lopez-Pajares V: Long non-coding RNA
regulation of gene expression during differentiation. Pflugers
Arch. 468:971–981. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ebisuya M, Yamamoto T, Nakajima M and
Nishida E: Ripples from neighbouring transcription. Nat Cell Biol.
10:1106–1113. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
40
|
Huang C, Yang Y and Liu L: Interaction of
long noncoding RNAs and microRNAs in the pathogenesis of idiopathic
pulmonary fibrosis. Physiol Genomics. 47:463–469. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Mercer TR, Dinger ME, Sunkin SM, Mehler MF
and Mattick JS: Specific expression of long noncoding RNAs in the
mouse brain. Proc Natl Acad Sci USA. 105:pp. 716–721. 2008;
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Rinn JL, Kertesz M, Wang JK, Squazzo SL,
Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E and
Chang Y: Functional demarcation of active and silent chromatin
domains in human HOX loci by noncoding RNAs. Cell. 129:1311–1323.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Willingham AT, Orth AP, Batalov S, Peters
EC, Wen BG, Aza-Blanc P, Hogenesch JB and Schultz PG: A strategy
for probing the function of noncoding RNAs finds a repressor of
NFAT. Science. 309:1570–1573. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Bayoglu B, Yuksel H, Cakmak HA, Dirican A
and Cengiz M: Polymorphisms in the long non-coding RNA CDKN2B-AS1
may contribute to higher systolic blood pressure levels in
hypertensive patients. Clin Biochem. 49:821–827. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Timofeeva MN, Hung RJ, Rafnar T,
Christiani DC, Field JK, Bickeböller H, Risch A, McKay JD, Wang Y,
Dai J, et al: Influence of common genetic variation on lung cancer
risk: Meta-analysis of 14 900 cases and 29 485 controls. Hum Mol
Genet. 21:4980–4995. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ørom UA, Derrien T, Beringer M, Gumireddy
K, Gardini A, Bussotti G, Lai F, Zytnicki M, Notredame C, Huang Q,
et al: Long noncoding RNAs with enhancer-like function in human
cells. Cell. 143:46–58. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Mattick JS: Linc-ing long noncoding RNAs
and enhancer function. Dev Cell. 19:485–486. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Cho RJ, Campbell MJ, Winzeler EA,
Steinmetz L, Conway A, Wodicka L, Wolfsberg TG, Gabrielian AE,
Landsman D, Lockhart DJ and Davis RW: A genome-wide transcriptional
analysis of the mitotic cell cycle. Mol Cell. 2:65–73. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Kruglyak S and Tang H: Regulation of
adjacent yeast genes. Trends Genet. 16:109–111. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Cohen BA, Mitra RD, Hughes JD and Church
GM: A computational analysis of whole-genome expression data
reveals chromosomal domains of gene expression. Nat Genet.
26:183–186. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
51
|
Quelle DE, Zindy F, Ashmun RA and Sherr
CJ: Alternative reading frames of the INK4a tumor suppressor gene
encode two unrelated proteins capable of inducing cell cycle
arrest. Cell. 83:993–1000. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Kamb A, Gruis NA, Weaver-Feldhaus J, Liu
Q, Harshman K, Tavtigian SV, Stockert E, Day RS III, Johnson BE and
Skolnick MH: A cell cycle regulator potentially involved in genesis
of many tumor types. Science. 264:436–440. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Huang SK, Scruggs AM, McEachin RC, White
ES and Peters-Golden M: Lung fibroblasts from patients with
idiopathic pulmonary fibrosis exhibit genome-wide differences in
DNA methylation compared to fibroblasts from nonfibrotic lung. PLoS
One. 9:e1070552014. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Li J, Bi L, Sun Y, Lu Z, Lin Y, Bai O and
Shao H: Text mining and network analysis of molecular interaction
in non-small cell lung cancer by using natural language processing.
Mol Biol Rep. 41:8071–8079. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Cisneros J, Hagood J, Checa M,
Ortiz-Quintero B, Negreros M, Herrera I, Ramos C, Pardo A and
Selman M: Hypermethylation-mediated silencing of p14(ARF) in
fibroblasts from idiopathic pulmonary fibrosis. Am J Physiol Lung
Cell Mol Physiol. 303:L295–L303. 2012. View Article : Google Scholar : PubMed/NCBI
|
